Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Excitotoxicity Markers and the Clinical-radiological Progression After a Demyelinating Event: a Prospective Pilot Study

NCT02523703 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT02523703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02523703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Excitotoxicity Markers and the Clinical-radiological Progression After a Demyelinating Event: a Prospective Pilot Study
Lead sponsor
University Hospital, Caen
Phase
Not applicable
Overall status
Completed
Start date
September 10, 2007
Completion date
February 23, 2015
Enrollment
36 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis